Abstract:Growth hormone (GH) release was studied in adults of normal stature, ages 21-86 yr. The subjects were 85-115% of ideal body weight, between the 5th and 95th percentiles in height, and free of active or progressive disease. 9 to 12 individuals in each decade from thirds to ninth were evaluated. The following criteria of GH status were measured: serum GH concentration, analyzed by radioimmunoassay at half-hour intervals for 4 h after onset of sleep, and at 1-h intervals from 8 a.m. to 4 p.m. in 52 subjects; daily retention of N, P, and K in response to 0.168 U human (h)GH/kg body wt3/4/day in 18 subjects; and plasma somatomedin C (SmC) level before and during exogenous hGH treatment in 18 subjects. All 10 individuals, 20-29 yr old, released substantial amounts of endogenous GH during both day and night (average peak serum GH obtained during day and night was 7.3 and 20.3 ng/ml, respectively); average plasma SmC was 1.43 U/ml (95% tolerance limits, 0.64-2.22 U/ml). There was no significant effect of exogenous hGH on elemental balances or on plasma SmC. In contrast, 6 of 12 individuals 60-79 yr old showed the following evidences of impaired GH release; peak waking and sleeping serum GH less than 4 ng/ml; plasma SmC less than 0.38 U/ml; a significant retention in N, P, and K; and a significant rise in plasma SmC, in response to exogenous hGH. Plasma SmC, serum GH during sleep, serum GH during the day, retentions of N, P, and K in response to exogenous hGH, and rise in plasma SmC in response to hGH were all intercorrelated (P less than 0.05). Plasma SmC less than 0.38 U/ml corresponded to peak nocturnal serum GH less than 4 ng/ml. The prevalence of plasma SmC less than 0.38 U/ml increased progressively from age 20 to 90: third decade, 0%; fourth, 11%; fifth, 20%; sixth, 22%; seventh, 42%; eight, 55%; and ninth, 55%. Within each decade, plasma SmC was inversely related to adiposity.

Virtual reality for simulation of radiographic projections: validation of projection geometry.

Celiac Disease and Neurological Manifestations: From Gluten to Neuroinflammation

Nutritional neuropathies

Neurological manifestations of gastrointestinal disorders, with particular reference to the differential diagnosis of multiple sclerosis

Small and Large Intestine (I): Malabsorption of Nutrients

Impaired growth hormone secretion in the adult population: relation to age and adiposity.

Effect of Iron Deficiency on Myelination in CNS

Sensory Axonopathy Associated With Vitamin E Deficiency

Nutrition and Disorders of Gut–Brain Interaction

Sensory Neuronopathy Revealing Severe Vitamin B12 Deficiency in a Patient with Anorexia Nervosa: An Often-Forgotten Reversible Cause

Fat emboli in bilateral total knee arthroplasty. Predictive factors for neurologic manifestations.

Celiac neuropathy

Neurologic Manifestations of Chronic Liver Disease and Liver Cirrhosis

Subacute combined degeneration associated with vitamin E deficiency due to small bowel obstruction: A case report

Summary of cancer of the larynx symposium.

A rare presentation of Wilson disease with neurological symptoms: Case report and genetic analysis

Gastrointestinal involvement in neuromuscular disorders

Fatal giant cell myocarditis after thymoma resection in myasthenia gravis.

Is there dietary macronutrient malabsorption in children with environmental enteropathy?

Alcoholic malnutrition and the small intestine

Neurological Deterioration in Wilson's Disease-Types, Etiology, Course, and Management